Healthcare conglomerate Johnson & Johnson kicked off its bankruptcy plan confirmation Tuesday, in its third attempt to ...
Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
In a report released today, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price ...
Genmab's Q4 2024 results impress with $897.4M revenue and 29% growth. GMAB's balance sheet is strong with nearly $3 billion ...
More than seven years after 34-year-old Keir Johnson and her 8-month-old daughter Chloe Johnson vanished from the peninsula, ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results